Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 24, 2026.

31 P magnetic resonance spectroscopy in skeletal muscle: Experts' consensus recommendations

Martin Meyerspeer, Chris Boesch, Donnie Cameron and 13 more

NMR in Biomedicine · 2020 · CC BY

doi:10.1002/nbm.4246

Abstract

Skeletal muscle phosphorus‐31 31 P MRS is the oldest MRS methodology to be applied to in vivo metabolic research. The technical requirements of 31 P MRS in skeletal muscle depend on the research question, and to assess those questions requires understanding both the relevant muscle physiology, and how 31 P MRS methods can probe it. Here we consider basic signal‐acquisition parameters related to radio frequency excitation, TR, TE , spectral resolution, shim and localisation. We make specific recommendations for studies of resting and exercising muscle, including magnetisation transfer, and for data processing. We summarise the metabolic information that can be quantitatively assessed with 31 P MRS, either measured directly or derived by calculations that depend on particular metabolic models, and we give advice on potential problems of interpretation. We give expected values and tolerable ranges for some measured quantities, and minimum requirements for reporting acquisition parameters and experimental results in publications. Reliable examination depends on a reproducible setup, standardised preconditioning of the subject, and careful control of potential difficulties, and we summarise some important considerations and potential confounders. Our recommendations include the quantification and standardisation of contraction intensity, and how best to account for heterogeneous muscle recruitment. We highlight some pitfalls in the assessment of mitochondrial function by analysis of phosphocreatine (PCr) recovery kinetics. Finally, we outline how complementary techniques (near‐infrared spectroscopy, arterial spin labelling, BOLD and various other MRI and 1 H MRS measurements) can help in the physiological/metabolic interpretation of 31 P MRS studies by providing information about blood flow and oxygen delivery/utilisation. Our recommendations will assist in achieving the fullest possible reliable picture of muscle physiology and pathophysiology.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 24, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction and Physiological (Metabolic) Background

31P MRS studies of skeletal muscle were among the first reported MRS studies of a mammalian organ in situ, and in four decades at least 500 such studies of human muscle have been published, more than of any other organ. MRS methods avoid serious limitations of the classical method for investigating cellular energetics in human skeletal muscle, namely biopsy; these include technical challenges of biochemical analysis (notably delayed metabolic arrest and the instability of high-energy phosphates, especially PCr, in samples before freezing/deproteination), difficulty of data acquisition during exercise (especially multiple measurements in kinetic studies), and limited acceptability, particularly for patients, in repeated or serial studies. Muscles can be studied in various functional states, from the resting state to full contractile activation (using voluntary exercise or electrical stimulation) and during post-exercise metabolic recovery, and in various experimental manipulations such as hypoxia and hyperoxia. In vivo 31P MRS can detect only free phosphorus-containing metabolites in tissue concentrations of ~100 μM and above, but these include key participants in ATP metabolism and the cellular functions it supports, notably mechanical force production. Here some brief physiological background will set the scene for the main subject of this consensus article, namely technical recommendations on 31P MRS muscle experiments and their interpretation.

Mammalian skeletal muscles are composed of multiple muscle cell types (‘myofibres’), of which there are three phenotypically distinct types functionally classified by their contractile and metabolic properties: slow-twitch oxidative (SO), fast-twitch oxidative glycolytic (FOG) and fast-twitch glycolytic (FG) myofibres, also known on the basis of their different expression of myosin motor proteins as Type I, Type IIa and Type IIb/x respectively. Metabolically, SO fibres are better equipped to oxidise fat and FG fibres to metabolise glucose and glycogen anaerobically to lactate (although they usually work aerobically, generating pyruvate), while FOG fibres are metabolically intermediate. Under normoxic conditions the mitochondrial reticulum is the main generator of the ATP that provides the energy for fibre contraction and relaxation; the energy available for work is measured by the strongly negative (i.e. far from thermodynamic equilibrium) cytosolic Gibbs free energy of ATP hydrolysis (ΔG ATP), which reflects a high ATP/ADP concentration ratio (~400 at rest). The contribution of anaerobic glycolytic adenosine diphosphate (ADP) phosphorylation* in resting normoxic skeletal muscle is negligible, but can far exceed mitochondrial ADP phosphorylation, particularly during high duty cycle, high power contractions. Myofibres are organised in phenotypically homogeneous clusters innervated by individual somatic neurons (‘motor units’), which are sequentially, not synchronously, recruited during voluntary exercise in a fixed order (SO → FOG → FG motor units) to produce mechanical force. This underlies the well-known metabolic shift from fat to carbohydrate oxidation during progressive exercise. It also complicates analysis and interpretation of in vivo 31P MRS muscle recordings in voluntary exercise at submaximal workloads, though this can be somewhat clarified by computational model-based analysis or alternative experimental strategies such as low-duty-cycle ballistic contractions or electrical stimulation.

Skeletal muscle is a convenient experimental model to study the ATP synthetic function of the mitochondrial network in situ, as it allows exercise studies† in which the metabolic load is manipulated via voluntary or electrically-stimulated contraction. Such dynamic 31P MRS exercise-recovery studies have contributed to understanding in vivo kinetic control of oxidative ADP phosphorylation in muscle. In ‘purely oxidative’ exercise (i.e. at moderate workloads below the mechanical threshold of FG motor unit recruitment) under steady-state conditions, mechanical work rate can be used as a surrogate for oxidative ADP phosphorylation rate, and its relationship to metabolic control signals such as free [ADP] or ΔG ATP (see Table 1) can be used– to make inferences about the muscle's capacity for oxidative ADP phosphorylation. This interpretation critically depends on localised 31P MRS signal collection in the active muscles only, and on accurate quantification of mechanical work. A more robust strategy, relatively independent of workload, is to study the kinetics of PCr resynthesis immediately following moderate exercise. The different technical and interpretative approaches are reviewed elsewhere, but the idea is that because PCr recovery is almost wholly fuelled by oxidative ATP synthesis, its kinetics reflect muscle ‘mitochondrial capacity’ (sometimes called Q max), which can be conceptualised as the inferred maximum rate of oxidative ADP phosphorylation under ‘maximum’ stimulation by 31P MRS-measurable negative feedback control signals such as [ADP] (although clearly stimulation by other factors, not measurable by 31P MRS, such as cytosolic Ca2+ or redox state will not be maximal during submaximal exercise).

Another long-standing theme in skeletal muscle physiology is to understand how chemical energy is transformed into mechanical force and power, how this process is controlled, and how it breaks down at high-contraction duty cycles (muscle fatigue). In vivo 31P MRS has made important contributions by correlating mechanical function with the calculated free intramuscular concentrations of ATP, ADP, Pi, Mg2+ and H+.– Also, in vivo 31P MRS can quantify contractile efficiency, as the ratio of muscle power or force output (normalised to muscle volume or cross-sectional area) to the total ADP phosphorylation rate, determined from dynamic 31P MRS measurements during electrical stimulation or voluntary exercise. This is most straightforwardly done by measuring the initial rate of PCr depletion,, although ways are described to estimate the relative contributions of the different ADP phosphorylation pathways, viz. the creatine kinase reaction, glycogenolysis and oxidative phosphorylation, as they evolve during exercise.

Exercise studies with 31P MRS have also contributed to understanding the control of glycolysis in muscle in vivo. – This is most straightforward during exercise under conditions of cuff ischaemia, where glycogenolytic ADP phosphorylation can be estimated from pH and PCr changes in a closed system where oxidative ADP phosphorylation and acid efflux are negligible., Some stoichiometric technicalities of the cellular metabolic production, consumption and buffering of acid (‘H+’ in shorthand form) are reviewed elsewhere.,

Introduction to the recommendations

Different scientific questions require particular experimental setups and focus on different metabolites, which imposes specific requirements for data quality, such as signal-to-noise ratio (SNR), linewidth, temporal resolution and extent of localisation. The MRS methodology must therefore be tailored to the specific application, while respecting constraints imposed by the instrumentation. SNR depends on, inter alia, field strength, coil sensitivity, size and location of the volume of interest (VOI) or voxel—namely, its distance from the coil element(s)—and the linewidth. The latter is, in turn, influenced by shim, and also size and location of the VOI. We make recommendations on signal acquisition for studies of resting muscle (with and without magnetisation transfer) and dynamic studies of muscle exercise. We discuss post-processing steps (fitting, quantifying and deriving physiological parameters from time series). We recommend units for reporting the results, and give some typical values expected in healthy subjects and patients. An overview of the most important recommendations is given at the end of this article. This brief summary can only highlight some important methodical aspects of 31P MRS and subject preparation but cannot go into depth and does not cover aspects of interpreting the data.

General features of acquisition

On most clinical MR systems, which are generally designed with 1H MRI as the main or only application, a package has to be acquired that allows 31P MRS. Such extensions generally enable the MR system to acquire signals from several ‘x-nuclei’ (i.e. nuclei other than 1H), and comprise additional hardware (usually a broadband amplifier, cabling, SAR supervision, receive system, and RF coils) and modifications of the scanner software. 31P MRS data acquisition should be optimised so that metabolites and derived measurements of interest (Table 1, Figure 1) are unambiguously detectable and quantifiable with sufficient SNR, while also fulfilling the demands imposed by the specificity of localisation, time resolution and exercise regime.

There are several aspects to consider:

The radio frequency (RF) excitation pulse bandwidth must be sufficiently large and the frequency profile should homogeneously excite all relevant metabolites for correct quantification. This is crucial for β-ATP, –16.26 ppm from PCr, if this resonance is to be used as a reference for absolute quantification (see also Table 2). Insufficient pulse bandwidth can produce strong chemical shift displacement artefacts when applying excitation with localisation gradients.

Flip angles of RF pulses should be known, as should the region over which the nominal flip angle applies when B 1 + fields are inhomogeneous.

Repetition time: Signal averaging with partially-saturated spectra increases SNR per unit time, with Ernst angle excitation being preferable. While maximum SNR per unit time is achieved with shortest TR (and correspondingly the smallest Ernst angle), longer repetition times, on the order of metabolite T 1 or more, are often chosen. This is advantageous because under partial saturation different T 1 values of resonances (see Table 2) affect relative peak amplitudes, which requires correction for quantification (see section 2.3.3). At TR = T 1 the theoretical signal reduction due to partial saturation is ~37 % with 90° excitation flip angle and ~27 % with the Ernst angle.

Spectral resolution must be high enough to resolve the metabolites of interest, for example PME, PDE, components of Pi or the split ATP resonances, (if measuring 31P-31P coupling constants or the phase evolution of the multiplets). This can also constrain the precision of pH quantification (see Table 1). If the chemical shift between Pi and PCr is measured in the spectral domain, zero-filling may enhance the nominal resolution in terms of Hz per spectral point in post-processing (section 2.3.1), and oversampling is often applied during acquisition but may be removed before data storage or data fitting.

Echo time: While T2 of most relevant metabolites is moderately long even at ultra-high field (> 100–400 ms, see Table 2), relatively short T 2 relaxation times, and homonuclear coupling of ATP leads to rapid signal decay after excitation, so non-echo-based MRS acquisitions with minimal acquisition delay are typically preferred for 31P MRS. Where echo-based acquisition is used, as in single voxel localisation in dynamic experiments, the echo time is preferably kept to a minimum and e.g. TE = 25 ms incurs only moderate signal loss for Pi at 7 T (T 2 = 109 ms). ATP concentration was successfully quantified with TE = 7.4 ms at 3 T, while long TE requires long acquisition times (~20 min with TE = 110 ms for T 2 measurements).

Shimming: Narrow linewidth is of particular importance at lower field strengths, where the bandwidth is relatively low and metabolites can overlap, thus impacting their measured chemical shift (e.g. for Pi, which reduces the precision of the pH calculation). Whatever shim method is used, it is important for dynamic studies that the shim parameters are robust against motion, which can be facilitated by generous volumes to optimize field homogeneity.

Nuclear Overhauser Effect (NOE): SNR enhancement via heteronuclear 1H-31P NOE is achieved with RF pulses on the 1H channel during the parts of TR not used for 31P transmission and reception. To translate increased SNR into improved accuracy, the enhancement should be calibrated for the given setup in test measurements to evaluate efficiency and reproducibility for each metabolite. Magnetization transfer effects observed between ATP phosphates have been attributed to homonuclear 31P-31P NOE as a result of dipolar cross-relaxation within the phosphate spin system of ATP, due to its transient binding to slowly-tumbling large molecules.

1H decoupling: Phosphate spins in mono- and diester groups are J-coupled with protons, which causes splitting of their resonances in the order of 7 Hz. As this splitting is not very well resolved it causes line broadening. By irradiation at the proper 1H frequency during acquisition it is possible to eliminate this coupling, which is particularly useful at field strengths of 3 T or below, where linewidths are in the order of the J-coupling. By 1H decoupling the signals of phosphocholine, phosphoethanolamine, GPC, GPE, α-ATP and NAD+ become much better detectable. 1H decoupling requires hardware adaptations to avoid 1H irradiation spoiling reception of the 31P signals.

Localisation can be implicitly set by the RF coil or explicitly defined via pulse sequences. Muscle 31P MRS is commonly, but not exclusively,, performed with surface RF coils, which provide inherent localisation via the spatial profile of their RF (Tx and Rx) fields. Coil placement merits attention for several reasons. Firstly, during limb exercise, activation is muscle-specific, depends on the exercise paradigm, and is heterogeneous along the length of the muscle. Secondly, in resting muscle, it is important to know which muscle the signal originates from, as muscles may be affected differently in disease, and may have different fibre-type compositions. Thirdly, because partial saturation depends on flip angle (which may vary over the sensitive volume), metabolite-specific T 1, and TR, partial saturation may complicate (even relative) quantification of spectra; this can be remedied by localised acquisition schemes. Finally, when classical RF pulses are transmitted with surface coils, signal from superficial tissue may be partially suppressed when adjusting optimal excitation to deeper regions. Similarly, when employing adiabatic pulses to enlarge the effective region of optimum excitation to deeper regions, superficial regions are also excited at the nominal flip angle, which may be undesirable. When large coils that encompass several muscle groups are used, at least simple localisation should be applied, to distinguish e.g. flexors from their antagonists (gastrocnemius and soleus vs. tibialis anterior in lower leg or the quadriceps and hamstrings in thigh) and muscles within a group that differ in fibre composition and contribute differently to exercise (like gastrocnemius and soleus in the calf). Several single-voxel, and multi-voxel localisation approaches,,, are available, each with specific advantages and drawbacks related to localisation power, time resolution, SNR, and ease of implementation. However, this is not required if the heterogeneity of the contributing tissue does not influence the interpretation of data and maximum SNR is critical, e.g. for PDE detection in small residual muscles of dystrophic patients. Optimal choice hence depends on the scientific question: see the following paragraphs on static and time-resolved dynamic MRS, and the scheme in section 2.4, Figure 4, for sensible combinations of techniques. In any case, realistic estimates of sensitive volume, contamination, and/or point spread function are necessary when designing a study.

Studies in the resting state

At rest, longer acquisition times result in higher SNR, which allows detection of species with low abundance and visibility such as PME, PDE, a recently identified alkaline Pi2 peak,, NAD(P)+/NAD(P)H and, indirectly, Mg2+. It also allows higher-precision quantification of ATP, as a reference standard for absolute quantification in the analysis of a subsequent exercise bout. Resting state measurements can use localisation methods like ISIS or classical spectroscopic imaging (MRSI), which are available on most clinical MR scanners but require relatively long acquisition times, and are hence unsuitable for dynamic experiments. Care should be taken to choose sufficiently large matrix sizes (minimum recommended: 8 x 8) and appropriate Hamming weighting to minimise contamination, and the field-of-view should be large enough to avoid aliasing, viz. approx. 20 × 20 cm for the leg.

Studies using magnetisation transfer

Magnetisation transfer (MT) experiments concern the selective perturbation of the equilibrium magnetisation of one or more spin systems of metabolite nuclei and detecting the transfer of this perturbation by chemical spin exchange to the same nuclei in other metabolites. Transfer can also occur by cross-relaxation to nuclei at other positions in the same metabolite (i.e. homonuclear Overhauser effect). Selective perturbation can be performed by either spin saturation (saturation transfer, ST) or inversion (inversion transfer, IT), after which the transfer is monitored on the resonances of the exchanging nuclei. In 31P MRS, saturation transfer has been most widely employed, typically to measure Pi ↔ ATP and PCr — ATP exchange fluxes by saturating the γ-ATP spin pool and detecting differences in the signal of either PCr or Pi (Figure 2).

To quantify the Pi ↔ ATP exchange, the pseudo first-order rate constant (k’), which can be derived from the Bloch equations incorporating chemical exchange, can be calculated as k’ = (M 0 – M Z) / (M 0 T 1*). In the case of measuring the Pi → ATP flux, M Z and M 0 are the equilibrium magnetisation of Pi under conditions of γ-ATP saturation and control respectively, and T 1* is the apparent T 1 of Pi in the presence of γ-ATP saturation, which generally has to be measured in vivo in an additional experiment. The Pi → ATP flux is then estimated by multiplying k’ by the concentration of Pi. Analogously, substituting for PCr signals and T 1* in the equations yields an estimate of the PCr → ATP flux. For implementation, the selective saturation of γ-ATP is best achieved using a long, low-power, frequency selective pulse; however, when MR hardware precludes a long (many seconds) continuous pulse, as can be the case with clinical scanners, a train of shorter pulses with minimal inter-pulse delay is effective if the saturation profile is carefully optimised., Signal saturation is verified by checking nulling of the saturated resonance in spectra acquired in vivo (see Figure 2). Off-resonance effects of the saturation pulse have to be taken into account, e.g. by alternating this pulse between being centred on the γ-ATP resonance and at a frequency equidistant to Pi (or PCr), i.e. ‘mirrored’ around the resonance of interest.

As spectra are typically acquired using surface coils, B 1 insensitive excitation and saturation pulses are preferred, and TR should be long enough to prevent artefacts arising due to differences in metabolite T 1 values between conditions of control and saturation of γ-ATP. Many averages are generally required to accurately determine signal changes. Measurements in human skeletal muscle have typically been made during resting conditions, although the Pi → ATP flux has also been determined during steady-state exercise.,

In the interpretation of ST results the potential involvement of small pools of metabolites, competing exchange reactions and homonuclear NOE may have to be considered., For instance, effects on the signal of β-ATP after saturating γ-ATP were not due to chemical exchange, but were found to be an intramolecular 31P-31P NOE, which was assigned to the transient binding of ATP to large molecular structures in muscle cells. Furthermore, Pi ↔ ATP exchange may have multiple origins in the cell. To tackle the potential problem of analysing multiple (competing) reactions the saturation of multiple resonances in ST and wide band inversion in IT have been implemented.,,

Although the potential of ST to detect exchange of small metabolite pools is of interest, it may be desirable to be sure that only MT effects among large pools are detected, which is achieved with IT methods. IT experiments have some advantages compared to ST experiments (e.g. no long saturation pulses, simultaneously measurable forward and reverse reactions), but the technique poses other challenges (e.g. T 2 relaxation during the inversion pulse). The application of ST at 3 T turned out to be more robust than the applied IT method. Both ST and IT techniques are further developed to make them more efficient.,

Dynamic (i.e. exercise/recovery) studies

Metabolic changes in muscle that can be observed with dynamic 31P MRS either occur on the time scale of a few seconds, such as pH at the onset and after cessation of exercise, or they have time constants of the order of half a minute, e.g. depletion of PCr during exercise and its post-exercise recovery, which can often be modelled as a mono-exponential function, or may have even longer time-courses e.g. post-exercise pH recovery. Hence, to capture changing pH and to reliably fit the PCr evolution with sufficient data points throughout exercise and recovery, the time resolution of repeatedly-acquired 31P spectra should be ~10 s or better. This temporal resolution necessitates shortening TR to the order of metabolite T 1 values and accepting partial saturation.

Choice of voxel size or coil should minimise signal contamination from adjacent non-exercising muscle tissue, taking account of the point spread function and expected SNR (and hence feasible time resolution). Temporal SNR, the ratio of the mean signal amplitude over time to its standard deviation, is more important in dynamic studies than the SNR of each individual acquisition. A smaller sensitive volume generally gives narrower lines, improving SNR and unique identification of peaks; inclusion of inactive muscle tissue will impair quantification of exercise-related changes in PCr breakdown and pH (which may also become ambiguous due to Pi splitting, as demonstrated in Figure 3). Strictly, such partial volume effects should not affect measured τ PCr (this being independent of absolute concentrations).‡

Practical aspects of exercising muscle in the scanner are considered later.

Preprocessing

When pulse-acquire techniques are used, the acquisition window may start too late to capture the first time points of the FID, especially when phase encoding gradients are following the excitation pulse or at higher field strengths where limited B 1 + results in longer excitation pulses. This should be accounted for in post-processing, by adjusting the first order phase (or ‘begin time’ in time domain) before fitting. The nominal resolution of frequency spectra can be increased via ‘zero-filling’, i.e. appending nulls to the acquisition vector, although anything beyond doubling the vector size brings no real benefit, merely improving spectral appearance. Spectral SNR can be enhanced and baseline oscillations (from truncated FIDs) can be reduced by apodisation, at the cost of increased linewidth. Optimal SNR improvement is achieved with a ‘matched filter’, i.e. one that corresponds to the natural linewidth.

Spectral fitting

Numerous tools are available for fitting 31P MRS data in time and frequency domains; however, few are well-suited to application to the large time-series of dynamic datasets. Popular software packages include jMRUI, OXSA, LC Model, TARQUIN and ACD Spectrus Platform.– Important considerations when selecting a spectral fitting method for 31P MRS are its capacity for batch processing, ability to handle baseline problems, output format of results, and reported error estimates. The AMARES fitting algorithm provided in the jMRUI and OXSA platforms is readily applied in batch mode. Error estimates, particularly the Cramér–Rao lower bound, permit additional quality control of metabolite fits, though these should be interpreted with care.

Quantifying concentrations

In 31P MRS, there are several means of quantifying concentrations (cf. Table 4 and the footnotes therein) of phosphorus metabolites, including absolute quantification using internal and external references, and relative methods using metabolite ratios. In relative methods, metabolite concentrations are commonly represented by ratios to ATP or (less usefully, because this changes during exercise) PCr, or to total phosphate (the sum of all quantifiable phosphorus resonances in the 31P spectrum, which remains near-constant during typical exercise). ATP is most frequently used as an ‘internal’ concentration reference standard, as [ATP] is relatively consistent between individuals and differs relatively little between fibre types in humans; a normal resting ATP concentration of 8.2 mM is conventionally assumed. In the quantification of time-series data, normalising concentration to a low-SNR metabolite such as ATP can introduce more error than it is worth: it is better to assume constant [ATP] and either reference to ATP signal acquired with high SNR at rest, or to assume approximately constant total 31P signal.§ Most internal-reference methods have used 1H-MRS-measured tissue water as a reference standard, after correcting for sensitivity differences between 31P and 1H channels.‖ External-reference methods have used standards like phenylphosphonic acid, monopotassium phosphate or hexamethylphosphorous triamide (tris (dimethylamino)phosphine). These have been applied either in the same experiment, or in separate experiments with the same volume of interest; this necessitates matching coil-loading between muscle and a phantom, an external reference to account for load differences, or use of a B 1 field map. An approach to account for varying coil-loading and receiver gains is to insert a synthetic reference signal via radiation (‘electronic reference to access in vivo concentrations’, ERETIC) or inductive coupling. Taking full account of the many confounding factors makes absolute quantitation technically demanding. Because T 1 and T 2 differ between metabolites (see Table 2), all quantification strategies require correction for saturation effects (unless acquired under fully relaxed conditions) and for T 2 (and J modulation of ATP) with echo-based acquisitions. Saturation correction can be done by taking the flip-angle dependent steady-state longitudinal magnetisation into account, using Mz(α, TR) ∝ (1 - e-TR/T1) / (1 – cos α · e-TR/T1). While the correction for exponential T 2-decay is straightforward (∝ e-TE/T2), the signal evolution with J depends on the pulse sequence and can be more complex than the cosine modulation applicable for a spin-echo sequence.

Fitting time-series

Several approaches to quantifying mitochondrial oxidative capacity depend on fitting the PCr resonance during recovery from exercise, and thus, on determining the time or rate constant of PCr resynthesis. Robust fitting necessitates precise determination of the end of exercise, and assignment of spectra to the correct time points in case of time-averaged data. Including differently active muscle groups inside the field-of-view may lead to mixed, multicomponent recovery curves. Acidosis has a complex retarding effect on PCr recovery, leading to a multi-exponential presentation if signals from regions of tissue exercised at different extent are mixed. We recommend evaluating pH for all time points in the exercise interval; if the measured pH deviates by an amount greater than about 0.1–0.2 units from baseline (in practice this is impossible to define more closely), results should be interpreted with caution. In well-localised data, a mono-exponential fit is recommended (see Table 1), although in the presence of significant pH changes this no longer represents the underlying data well. Some investigators have proposed the use of bi-exponential or Weibull functions in these instances, to extract the ‘early-recovery’ component, but these methods are not definitive.

Recommended combinations of instrumentation and RF pulse sequences

The technical requirements on 31P MRS data follow from the research question or application. Given that, different combinations of MRS methodologies can be recommended, within the constraints imposed by the available instrumentation (field strength, available RF coils) and, to a lesser extent, pulse sequences. Figure 4 gives an overview of recommended combinations for studies of resting muscle and for dynamic studies. Different quality in terms of SNR and hence feasible time resolution is to be expected from the different setups. The RF coil and its sensitive volume, voxel size and position, i.e. relative distance to the coil, have a strong influence on SNR with localising sequences, and some pulse sequences like classical MRSI with Cartesian read-out or 3D ISIS may not provide the required time resolution for dynamic acquisitions using standard exercise protocols, although a gated 31P 2D MRSI protocol has been implemented with repeated rapid dynamic contractions., Further influences are TR, TE, readout bandwidth and post-processing steps like the algorithm for combination of signals from different coil channels. Generally, the larger the signal-contributing volume, the larger is the SNR but besides the introduction of partial volume effects, linewidth increases. In Figure 4 coil types are separated into surface and volume coils, while array coils can fall into either of these categories. An array coil can provide the high SNR of surface coils or better, with a big field of view and homogeneous excitation via (static) B 1 + shimming, depending on the coil design.

Typical values of measurements

As a practical guide to help in assessing implementation of experimental protocols, Table 2 gives typical values of some measured and calculated quantities in human skeletal muscle.

Reporting in publications

When reporting results it is important to consider what information is required for others to understand and follow to replicate the acquisition and quantification protocol. Not all parameters or equations need to be reported in the main text of every manuscript; referencing or inclusion as supplementary material is recommended.

Table 3 summarises the essential information that we recommend should be reported, and Table 4 gives the units in which the quantified metabolic parameters should be reported in publications, to allow straightforward comparison with the published literature.

MR and Non-MR Techniques Complementary to 31P MRS

Several techniques can help 31P MRS demarcate physiology from pathophysiology by providing information about blood flow and oxygen delivery/utilisation. Near-infrared spectroscopy (NIRS) can assess relative concentration changes in oxygenated, deoxygenated and total haem. Unfortunately, the NIRS signals from (intracellular) myoglobin (Mb) and (intravascular) haemoglobin (Hb) overlap. Conventional analysis attributed the muscle signal to Hb. Recent work combining NIRS with 1H MRS, which can distinguish Mb and Hb signals, has now clarified these contributions: NIRS mainly reports the oxygenation of Mb.– Combining NIRS and 31P MRS offers an opportunity to better understand adaptation and capacity in contracting muscle.

The use of simultaneous measures of electromyography and 31P MRS can be used to identify the mechanisms of muscle fatigue in vivo and improve interpretation of the metabolic responses to incomplete voluntary activation of skeletal muscle.

Arterial spin labelling (ASL) MRI assesses blood perfusion and blood oxygen level dependent (BOLD) imaging can monitor regional oxygen changes. Interpreting BOLD requires caution, because many confounding factors can affect the T 2* weighted images, notably pH change. To reduce potential confounding variables, protocols consisting of brief contractions have been developed.

Acquiring simultaneously or interleaved 1H MR and 31P MR signals enables the capture of complementary metabolic information during a single exercise bout. Studies have combined 31P MRS with 1H MR to measure BOLD signals,, perfusion,– Mb and intracellular O2,,, lactate, and most recently carnosine. Such interleaved measurements require modification of pulse programs and sometimes hardware.,

Finally, metabolite-specific 31P MRI can localise metabolite signals and pH within a tissue region,, and new ideas such as fingerprinting and artificial intelligence-based approaches for 31P and metabolite kinetics are being developed, but this topic extends beyond the present scope.

Muscle, muscle size, mode of exercise

The choice of muscle will determine the choice of exercise and vice versa. Different ways to apply exercise load range from simple rubber bands, through lifting of weights, to highly sophisticated ergometers., A factor to consider in the interpretation is the size of the recruited muscle affecting the observed metabolic signals ([CO2], [H+], lactate, [O2], free radicals) involved in the homeostatic cardiovascular and ventilatory responses. Another is the degree of eccentric vs. isometric/concentric exercise, as their molecular mechanisms differ, which results in different haemodynamic and metabolic responses.

Determining contraction intensity is a pre-requisite for in-magnet exercise studies, especially those that relate intensity to changes in PCr or similar measurements. On-line monitoring of the subject's activity and storage of these motion data is desirable, as it allows monitoring the subject's compliance to the protocol, ensures correct assignment of exercise and recovery phases, and identifies motion artefacts, all of which helps to improve data quality. However, accurate load measurement in the MR environment via sensors capturing force and motion is not trivial, and requires dedicated MR-compatible systems (e.g. optical equipment). The heterogeneity of muscle recruitment needs to be considered in the interpretation of exercise-induced metabolic changes, as it can be highly inhomogeneous, e.g. even among plantar flexors and along muscles,, as recent localised 7 T experiments have shown. The scope for extraneous movements must be minimised. Comfortable yet tight fixation and careful reproduction of the positioning between subjects in longitudinal studies will contribute to reliability. Exact adherence to exercise timing is crucial (e.g. a ‘clean’ cessation for measurement of PCr recovery kinetics). Better protocol adherence can be obtained with electrostimulation; however, temporal and spatial recruitment differ substantially from voluntary contractions and result in different haemodynamics and metabolic perturbations. While motor nerve stimulation can activate all motor units, it can be problematic (activating antagonists, being painful or increasing risk of injury). In contrast, motor point stimulation activates only a portion of the muscle.

PCr recovery kinetics

Mono-exponential PCr recovery is less dependent on exact exercise intensity than methods that study the PCr decrease or Pi increase as a function of load. To measure PCr recovery kinetics, the exercise bouts must be intense enough to induce a substantial (30–40 %) PCr depletion while pH should not decrease more than 0.1 – ~0.2 units, as this complicates the kinetics and interpretation of PCr recovery (see above). To achieve this, a preliminary incremental/ramp protocol can be used to determine the workload corresponding to the onset of acidosis; alternatively, each subject's maximum voluntary force may be determined to scale the workload, though this may not be feasible in some patient populations. Use of relatively brief, maximal voluntary contractions ensures that all motor units are activated while keeping acidosis to a minimum. A different approach to measuring PCr recovery kinetics without complicating pH change is to use brief ‘pulses’ of muscle stimulation, multiply-averaged to improve SNR (usefully, this also allows estimation of ATP usage rate during the stimulation (exercise) period). Reproducibility of PCr recovery kinetics can be optimised with some warm-up exercise.

It is important that the experimental setup is not allowed to influence muscle blood flow (e.g. hindering it by fixed joint position or isometric/eccentric load). In the extreme case, stoppage of blood flow by cuff ischaemia will completely stop PCr recovery.

Recommended steps of a dynamic MR examination

For a dynamic MR examination we recommend evaluating the clinical status of the subjects and their ability to undergo the exercise. Next consider the choice of parameters that can be measured using an available ergometer. Finally, adjust the dynamic protocol (i.e. with both concentric and eccentric phases) to suit the subjects and the available ergometer.

It is desirable that a test–retest should be performed and reported for each specific protocol.,

Reliable examinations depend critically on a reproducible setup, standardised preconditioning of the subject, and control of potential difficulties. Table 5 lists some relevant considerations and potential confounders; these may be unavoidable, but should be documented in ‘Material and Methods’ or the ‘Discussion’ section.

Interpreting resting data

In general the resting values of quantities measured by 31P MRS are set by an interacting combination of mechanisms including the kinetic properties of transmembrane transport of Pi, creatine, and H+, and the regulation of basal ATP synthesis rate.,, Any of these might differ between fibre types, with training state or age, and in disease.

Resting metabolite concentrations differ between myofibre subtypes (more so in rodents than human), and so inferences about fibre-type composition have been made on the basis of resting PCr/Pi and PCr/ATP ratios, albeit with differing findings.,

The lower PCr/ATP and PCr/Pi ratios and higher Pi/ATP seen in resting muscles of patients with genetic defects in mitochondrial oxidative ADP phosphorylation can largely be explained in terms of the primary pathology. In muscular dystrophies elevated resting intramuscular pH, probably relates to membrane leakage and sodium accumulation with associated ‘compensatory’ proton extrusion; in some patients, multiple Pi resonances suggest pH heterogeneity. Increased PDE/ATP ratios in muscular dystrophy,, fibromyalgia, and the elderly are thought to reflect elevated membrane turnover and disturbed phospholipid metabolism. Free intramuscular Mg2+ concentration is decreased in Duchenne muscular dystrophy, a likely consequence of membrane leakiness.

Interpreting PCr kinetics during exercise and recovery: Mitochondrial function

The simplest cases of exercise protocols are ‘pure oxidative’ exercise at constant power, or recovery from such exercise, where the rate constant of the change in PCr (decrease during exercise, resynthesis during recovery) is proportional to the mitochondrial capacity measured in various other ways.– This interpretation is complicated when there is pronounced pH change during exercise due to significant non-oxidative glycolytic contribution to ATP synthesis. Kinetics of PCr change during exercise then become an unreliable quantitative guide to mitochondrial function (although impaired mitochondrial function is likely to lead, other things being equal, to greater changes in PCr during exercise). Furthermore, in recovery from exercise with a physiologically significant pH decrease (say >0.2), the interactions between pH, ADP and PCr concentrations via the CK equilibrium result in a relationship between end-exercise pH and PCr recovery kinetics (lower pH, slower recovery), independent of changes in mitochondrial capacity.– Various ways, with some theoretical support and proven empirical utility, have been devised to correct for this effect. Some of these methods of calculation and interpretation yield estimates of mitochondrial capacity in units of absolute metabolic flux, but their relationship to measures made by invasive physiological or ex vivo biochemical measurements is not yet completely understood.

Conducting the exercise so as to minimise muscle acidification allows simply using the rate constant of PCr recovery as a measure of whole-muscle oxidative capacity, rather than ‘mitochondrial capacity’, per se. This is a system property with contributions from a number of factors including the number of mitochondria, the amount and the activity per mitochondrion of respiratory chain components and enzymes of fat and carbohydrate oxidation, but also the vascular supply of O2, and the diffusion of O2 across the capillary wall and through the myocyte to the mitochondria. A slow PCr recovery may reflect impairment of any of these processes. Situations in which O2 availability is changed, such as in peripheral vascular disease, reactive hyperaemia, experimental hypoxia in untrained subjects, and chronic obstructive pulmonary disease, are particularly likely to be confounded. However, in the submaximal exercise typically used in 31P MRS work, one would not (in normoxia) expect whole-body cardiovascular or respiratory function to affect 31P MRS measures of mitochondrial function, and the relevant factors are distal to the artery supplying the muscle studied.

Interpreting other features of dynamic 31P MRS studies

The assessment of contractile cost from the initial rate of PCr depletion using exercise is reasonably uncontroversial, providing a reliable measure of mechanical output is available. This is an interesting and potentially useful physiological property, but relatively under-studied.

Changes in pH during exercise and recovery depend on passive buffering processes, the acidifying effect of glycolytic ATP synthesis (an accompaniment of lactate production) and the pH-restoring effects of processes of acid efflux. Although the principles are reasonably clear, the quantitative details are not necessarily well understood, and physiological validation by other methods is rare. In some cases the (patho)physiological interpretation is straightforward. For example, if glycogenolysis is absent, as in the metabolic disorder McArdle's disease (muscle glycogen phosphorylase deficiency), exercise produces a characteristic and quantifiable pattern of 31P MRS abnormalities. If more subtle changes in glycogenolysis are of interest, it makes sense to study the muscle in ischaemic exercise, where there is no oxidative contribution to ATP synthesis. Another simple example: when peripheral vascular disease impairs the ability to clear acid from the muscle cell, pH recovery after exercise is slowed, pH and PCr recovery kinetics can be used to estimate absolute rates of post-exercise acid efflux, but this has rarely been exploited in disease.

In acidifying exercise the presence of different-pH components as ‘splitting’ of the cytosolic Pi resonance may be an index of different responses by the various myofibre types,, provided localisation is adequate to ensure that the heterogeneity is within a single muscle., Inference must be very cautious here.

Interpreting magnetisation transfer measurements

Pi → ATP flux measured by MT in resting muscle has been suggested to reflect mainly oxidative ATP synthesis, on the two assumptions that this is unidirectional (so that exchange flux ≈ net rate of ATP synthesis) and that other contributions (e.g. near-equilibrium exchange via the glycolytic enzymes GAPDH and PGK) are relatively small. However, observed rates of Pi → ATP flux are much larger than known rates of oxidative ATP synthesis in resting muscle, so one or both assumptions must be wrong. Recent measurements of Pi → ATP flux during steady-state exercise in human muscle show that this discrepancy is approximately independent of ATP turnover. Despite these physiological uncertainties, which argue against any simple conceptual relationship between the two quantities, resting Pi → ATP flux was previously proposed to be an indirect measure of mitochondrial capacity. It is unsurprising that some studies show no empirical relationship between them. More puzzlingly, some studies do show some interesting correlations between resting Pi → ATP flux and measures of resting ATP turnover and mitochondrial capacity; the physiological basis of these remains unexplained.

Conclusions

Skeletal muscle 31P MR spectroscopy can provide insights, not otherwise available non-invasively, into the regulation and pathophysiology of what may be summarised as cellular energy metabolism or ‘bioenergetics’: the production and use of ATP. Most common is the use of voluntary exercise or electrical stimulation as a dynamic probe to assess the metabolic response to increased workload. The post-exercise kinetics of PCr resynthesis offer the most straightforward way of quantifying the rate and capacity of mitochondrial ATP synthesis, best considered as a system function of the organ and its blood supply. Changes in cytosolic pH reflect the balance of anaerobic glycolytic ATP synthesis and the processes of acid efflux. The use of 31P MRS in resting muscle can profit from increased SNR due to longer acquisition times, which allows relatively easy application of localisation schemes. This has been exploited particularly for studying various diseases. Combining 31P MRS with other methods can add valuable complementary information on O2 delivery, amongst other things.

The recommendations given here, of which the most important ones are listed in Table 6, are intended to guide those who have experience in general MRS to the special application of 31P MRS in skeletal muscle, covering the practicalities of acquisition and exercise as well as the physiological interpretation of the measurements.

References 138

  1. 1.

    Chance B, Im J, Nioka S, Kushmerick M. Skeletal muscle energetics with PNMR: personal views and historic perspectives. NMR Biomed. 2006;19(7):904-926.

    Not in our library10.1002/nbm.1109

  2. 2.

    Meyer RA, Brown TR, Kushmerick MJ. Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle. Am J Physiol. 1985;248(3 Pt 1):C279-C287.

    Not in our library10.1152/ajpcell.1985.248.3.c279

  3. 3.

    Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev. 2011;91(4):1447-1531.

    Not in our library10.1152/physrev.00031.2010

  4. 4.

    Glancy B, Hartnell LM, Malide D, et al. Mitochondrial reticulum for cellular energy distribution in muscle. Nature. 2015;523(7562):617-620.

    Not in our library10.1038/nature14614

  5. 5.

    Lanza IR, Wigmore DM, Befroy DE, Kent-Braun JA. In vivo ATP production during free-flow and ischaemic muscle contractions in humans. J Physiol. 2006;577:353-367.

    Not in our library10.1113/jphysiol.2006.114249

  6. 6.
  7. 7.

    Diekman EF, Visser G, Schmitz JP, et al. Altered energetics of exercise explain risk of rhabdomyolysis in very long-chain acyl-CoA dehydrogenase deficiency. PLoS ONE. 2016;11(2):e0147818.

    Not in our library10.1371/journal.pone.0147818

  8. 8.

    Jeneson JA, van Dobbenburgh JO, van Echteld CJ, et al. Experimental design of 31P MRS assessment of human forearm muscle function: restrictions imposed by functional anatomy. Magn Reson Med. 1993;30(5):634-640.

    Not in our library10.1002/mrm.1910300515

  9. 9.

    Blei ML, Conley KE, Kushmerick MJ. Separate measures of ATP utilization and recovery in human skeletal muscle. J Physiol. 1993;465:203-222.

    Not in our library10.1113/jphysiol.1993.sp019673

  10. 10.

    Chance B, Leigh JS, Clark BJ, et al. Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function. Proc Natl Acad Sci U S A. 1985;82(24):8384-8388.

    Not in our library10.1073/pnas.82.24.8384

  11. 11.

    Vicini P, Kushmerick MJ. Cellular energetics analysis by a mathematical model of energy balance: estimation of parameters in human skeletal muscle. Am J Physiol Cell Physiol. 2000;279(1):C213-C224.

    Not in our library10.1152/ajpcell.2000.279.1.c213

  12. 12.

    Meyer RA. A linear model of muscle respiration explains monoexponential phosphocreatine changes. Am J Physiol. 1988;254(4 Pt 1):C548-C553.

    Not in our library10.1152/ajpcell.1988.254.4.c548

  13. 13.

    Jeneson JA, Westerhoff HV, Brown TR, Van Echteld CJ, Berger R. Quasi-linear relationship between Gibbs free energy of ATP hydrolysis and power output in human forearm muscle. Am J Physiol. 1995;268(6 Pt 1):C1474-C1484.

    Not in our library10.1152/ajpcell.1995.268.6.c1474

  14. 14.

    Kemp GJ, Ahmad RE, Nicolay K, Prompers JJ. Quantification of skeletal muscle mitochondrial function by 31P magnetic resonance spectroscopy techniques: a quantitative review. Acta Physiol (Oxf). 2015;213(1):107-144.

    Not in our library10.1111/apha.12307

  15. 15.

    Calderon JC, Bolanos P, Caputo C. The excitation-contraction coupling mechanism in skeletal muscle. Biophys Rev. 2014;6(1):133-160.

    Not in our library10.1007/s12551-013-0135-x

  16. 16.

    Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms. Physiol Rev. 2008;88(1):287-332.

    Not in our library10.1152/physrev.00015.2007

  17. 17.

    Kent-Braun JA, Fitts RH, Christie A. Skeletal muscle fatigue. Compr Physiol. 2012;2:997-1044.

    Not in our library10.1002/cphy.c110029

  18. 18.

    Dawson MJ, Gadian DG, Wilkie DR. Muscular fatigue investigated by phosphorus nuclear magnetic resonance. Nature. 1978;274(5674):861-866.

    Not in our library10.1038/274861a0

  19. 19.

    Meyer RA, Kuchmerick MJ, Brown TR. Application of 31P-NMR spectroscopy to the study of striated muscle metabolism. Am J Physiol. 1982;242(1):C1-C11.

    Not in our library10.1152/ajpcell.1982.242.1.c1

  20. 20.

    Foley JM, Meyer RA. Energy cost of twitch and tetanic contractions of rat muscle estimated in situ by gated 31P NMR. NMR Biomed. 1993;6(1):32-38.

    Not in our library10.1002/nbm.1940060106

  21. 21.

    Fiedler GB, Schmid AI, Goluch S, et al. Skeletal muscle ATP synthesis and cellular H+ handling measured by localized 31P-MRS during exercise and recovery. Sci Rep. 2016;6.

    Not in our library10.1038/srep32037

  22. 22.

    Conley KE, Blei ML, Richards TL, Kushmerick MJ, Jubrias SA. Activation of glycolysis in human muscle in vivo. Am J Physiol. 1997;273(1 Pt 1):C306-C315.

    Not in our library10.1152/ajpcell.1997.273.1.c306

  23. 23.

    Crowther GJ, Carey MF, Kemper WF, Conley KE. Control of glycolysis in contracting skeletal muscle. I. Turning it on. Am J Physiol Endocrinol Metab. 2002;282(1):E67-E73.

    Not in our library10.1152/ajpendo.2002.282.1.e67

  24. 24.

    Lambeth MJ, Kushmerick MJ. A computational model for glycogenolysis in skeletal muscle. Ann Biomed Eng. 2002;30(6):808-827.

    Not in our library10.1114/1.1492813

  25. 25.

    Schmitz JP, Groenendaal W, Wessels B, et al. Combined in vivo and in silico investigations of activation of glycolysis in contracting skeletal muscle. Am J Physiol Cell Physiol. 2013;304(2):C180-C193.

    Not in our library10.1152/ajpcell.00101.2012

  26. 26.

    Kemp GJ, Roussel M, Bendahan D, Le Fur Y, Cozzone PJ. Interrelations of ATP synthesis and proton handling in ischaemically exercising human forearm muscle studied by 31P magnetic resonance spectroscopy. J Physiol. 2001;535(Pt 3):901-928.

    Not in our library10.1111/j.1469-7793.2001.00901.x

  27. 27.

    Kemp GJ. Lactate accumulation, proton buffering, and pH change in ischemically exercising muscle. Am J Physiol Regul Integr Comp Physiol. 2005;289(3):R895-R901.

    Not in our library10.1152/ajpregu.00641.2004

  28. 28.

    Kemp GJ, Boning D, Beneke R, Maassen N. Explaining pH change in exercising muscle: lactic acid, proton consumption, and buffering vs. strong ion difference. Am J Physiol Regul Integr Comp Physiol. 2006;291(1):R235-R237.

    Not in our library10.1152/ajpregu.00662.2005

  29. 29.

    Kemp GJ, Meyerspeer M, Moser E. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review. NMR Biomed. 2007;20(6):555-565.

    Not in our library10.1002/nbm.1192

  30. 30.

    Ernst RR, Anderson WA. Application of Fourier transform spectroscopy to magnetic resonance. Rev Sci Instrum. 1966;37(1):93-102.

    Not in our library

  31. 31.

    de Graaf RA. In vivo NMR. Spectroscopy. 2019;550.

    Not in our library

  32. 32.

    Meyerspeer M, Krššák M, Moser E. Relaxation times of 31P-metabolites in human calf muscle at 3 T. Magn Reson Med. 2003;49(4):620-625.

    Not in our library10.1002/mrm.10426

  33. 33.

    Bogner W, Chmelík M, Schmid AI, Moser E, Trattnig S, Gruber S. Assessment of 31P relaxation times in the human calf muscle: a comparison between 3 T and 7 T in vivo. Magn Reson Med. 2009;62(3):574-582.

    Not in our library10.1002/mrm.22057

  34. 34.

    Meyerspeer M, Scheenen T, Schmid AI, Mandl T, Unger E, Moser E. Semi-LASER localized dynamic 31P magnetic resonance spectroscopy in exercising muscle at ultra-high magnetic field. Magn Reson Med. 2011;65(5):1207-1215.

    Not in our library10.1002/mrm.22730

  35. 35.

    Nabuurs C, Huijbregts B, Wieringa B, Hilbers CW, Heerschap A. 31P saturation transfer spectroscopy predicts differential intracellular macromolecular association of ATP and ADP in skeletal muscle. J Biol Chem. 2010;285:39588-39596.

    Not in our library10.1074/jbc.m110.164665

  36. 36.

    Luyten PR, Bruntink G, Sloff FM, et al. Broadband proton decoupling in human 31P NMR spectroscopy. NMR Biomed. 1989;1:177-183.

    Not in our library10.1002/nbm.1940010405

  37. 37.

    Hooijmans MT, Niks EH, Burakiewicz J, Verschuuren JJGM, Webb AG, Kan HE. Elevated phosphodiester and T 2 levels can be measured in the absence of fat infiltration in Duchenne muscular dystrophy patients. NMR Biomed. 2017;30:e3667.

    Not in our library10.1002/nbm.3667

  38. 38.

    Wokke BH, Hooijmans MT, van den Bergen JC, Webb AG, Verschuuren JJ, Kan HE. Muscle MRS detects elevated PDE/ATP ratios prior to fatty infiltration in Becker muscular dystrophy. NMR Biomed. 2014;27(11):1371-1377.

    Not in our library10.1002/nbm.3199

  39. 39.

    Niess F, Fiedler GB, Schmid AI, et al. Dynamic multivoxel-localized 31P MRS during plantar flexion exercise with variable knee angle. NMR Biomed. 2018;31(6):e3905.

    Not in our library10.1002/nbm.3905

  40. 40.

    Boss A, Heskamp L, Breukels V, Bains LJ, van Uden MJ, Heerschap A. Oxidative capacity varies along the length of healthy human tibialis anterior. J Physiol. 2018;596:1467-1483.

    Not in our library10.1113/jp275009

  41. 41.

    Hooijmans MT, Doorenweerd N, Baligand C, et al. Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up. PLoS ONE. 2017;12:1-15.

    Not in our library10.1371/journal.pone.0182086

  42. 42.

    Kan HE, Klomp DW, Wohlgemuth M, et al. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism. NMR Biomed. 2010;23(6):563-568.

    Not in our library10.1002/nbm.1494

  43. 43.

    Edgerton VR, Smith JL, Simpson DR. Muscle fibre type populations of human leg muscles. Histochem J. 1975;7(3):259-266.

    Not in our library10.1007/bf01003594

  44. 44.

    Meyerspeer M, Robinson S, Nabuurs CI, et al. Comparing localized and nonlocalized dynamic 31P magnetic resonance spectroscopy in exercising muscle at 7T. Magn Reson Med. 2012;68:1713-1723.

    Not in our library10.1002/mrm.24205

  45. 45.

    Valkovič L, Chmelík M, Just Kukurová I, et al. Depth-resolved surface coil MRS (DRESS)-localized dynamic 31P-MRS of the exercising human gastrocnemius muscle at 7 T. NMR Biomed. 2014;27(11):1346-1352.

    Not in our library10.1002/nbm.3196

  46. 46.

    Slade JM, Towse TF, Delano MC, Wiseman RW, Meyer RA. A gated 31P NMR method for the estimation of phosphocreatine recovery time and contractile ATP cost in human muscle. NMR Biomed. 2006;19(5):573-580.

    Not in our library10.1002/nbm.1037

  47. 47.

    Schmid AI, Meyerspeer M, Robinson SD, et al. Dynamic PCr and pH imaging of human calf muscles during exercise and recovery using 31P gradient-Echo MRI at 7 tesla. Magn Reson Med. 2016;75:2324-2331.

    Not in our library10.1002/mrm.25822

  48. 48.

    Reyngoudt H, Lopez Kolkovsky AL, Carlier PG. Free intramuscular Mg2+ calculated using both 31P and 1H NMRS-based pH in skeletal muscle of Duchenne muscular dystrophy patients. NMR Biomed. 2019;e4115.

    Not in our library10.1002/nbm.4115

  49. 49.

    Wary C, Azzabou N, Giraudeau C, et al. Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy. NMR Biomed. 2015;28:1150-1162.

    Not in our library10.1002/nbm.3352

  50. 50.

    Kan HE, Klomp DWJ, Wong CS, et al. In vivo 31P MRS detection of an alkaline inorganic phosphate pool with short T 1 in human resting skeletal muscle. NMR Biomed. 2010;23:995-1000.

    Not in our library10.1002/nbm.1517

  51. 51.

    Scheenen TWJ, Klomp DWJ, Wijnen JP, Heerschap A. Short echo time 1H-MRSI of the human brain at 3T with minimal chemical shift displacement errors using adiabatic refocusing pulses. Magn Reson Med. 2008;59:1-6.

    Not in our library10.1002/mrm.21302

  52. 52.

    Bottomley PA. Measuring biochemical reaction rates in vivo with magnetization transfer. eMagRes. 2016;5:843-858.

    Not in our library

  53. 53.

    Buehler T, Kreis R, Boesch C. Comparison of 31P saturation and inversion magnetization transfer in human liver and skeletal muscle using a clinical MR system and surface coils. NMR Biomed. 2015;28:188-199.

    Not in our library10.1002/nbm.3242

  54. 54.

    Sleigh A, Savage DB, Williams GB, et al. 31P magnetization transfer measurements of pi→ATP flux in exercising human muscle. J Appl Physiol. 2016;120:649-656.

    Not in our library10.1152/japplphysiol.00871.2015

  55. 55.

    Tušek Jelenc M, Chmelík M, Bogner W, Krššák M, Trattnig S, Valkovič L. Feasibility and repeatability of localized 31P-MRS four-angle saturation transfer (FAST) of the human gastrocnemius muscle using a surface coil at 7T. NMR Biomed. 2016;29:57-65.

    Not in our library10.1002/nbm.3445

  56. 56.

    Balaban RS, Koretsky AP. Interpretation of 31P NMR saturation transfer experiments: what you can't see might confuse you. Focus on standard magnetic resonance-based measurements of the Pi → ATP rate do not index the rate of oxidative phosphorylation in cardiac and skeletal muscles. Am J Physiol Cell Physiol. 2011;301:12-15.

    Not in our library10.1152/ajpcell.00100.2011

  57. 57.

    Nabuurs CI, Hilbers CW, Wieringa B, Heerschap A. Letter to the editor: “Interpretation of 31P NMR saturation transfer experiments: do not forget the spin relaxation properties”. Am J Physiol Cell Physiol. 2012.

    Not in our library10.1152/ajpcell.00409.2011

  58. 58.

    Kemp GJ, Brindle KM. What do magnetic resonance-based measurements of Pi→ATP flux tell us about skeletal muscle metabolism? Diabetes. 2012;61(8):1927-1934.

    Not in our library10.2337/db11-1725

  59. 59.

    Pouymayou B, Buehler T, Kreis R, Boesch C. Test–retest analysis of multiple 31P magnetization exchange pathways using asymmetric adiabatic inversion. Magn Reson Med. 2017;78:33-39.

    Not in our library10.1002/mrm.26337

  60. 60.

    Ren J, Sherry AD, Malloy CR. Amplification of the effects of magnetization exchange by 31P band inversion for measuring adenosine triphosphate synthesis rates in human skeletal muscle. Magn Reson Med. 2015;74:1505-1514.

    Not in our library10.1002/mrm.25514

  61. 61.

    Ren J, Sherry AD, Malloy CR. Modular 31P wideband inversion transfer for integrative analysis of adenosine triphosphate metabolism, T 1 relaxation and molecular dynamics in skeletal muscle at 7T. Magn Reson Med. 2019;81:3440-3452.

    Not in our library10.1002/mrm.27686

  62. 62.

    Naressi A, Couturier C, Devos J, et al. Java-based graphical user interface for the MRUI quantitation package. Magn Reson Mater Phy. 2001;12(2–3):141-152.

    Not in our library10.1007/bf02668096

  63. 63.
  64. 64.

    Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6):672-679.

    Not in our library10.1002/mrm.1910300604

  65. 65.

    Wilson M, Reynolds G, Kauppinen RA, Arvanitis TN, Peet AC. A constrained least-squares approach to the automated quantitation of in vivo 1H magnetic resonance spectroscopy data. Magn Reson Med. 2011;65(1):1-12.

    Not in our library10.1002/mrm.22579

  66. 66.

    Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129(1):35-43.

    Not in our library10.1006/jmre.1997.1244

  67. 67.

    Kreis R. The trouble with quality filtering based on relative Cramér-Rao lower bounds. Magn Reson Med. 2016;75(1):15-18.

    Not in our library10.1002/mrm.25568

  68. 68.

    Buchli R, Boesiger P. Comparison of methods for the determination of absolute metabolite concentrations in human muscles by 31P MRS. Magn Reson Med. 1993;30(5):552-558.

    Not in our library10.1002/mrm.1910300505

  69. 69.

    Barantin L, Le Pape A, Akoka S. A new method for absolute quantitation of MRS metabolites. Magn Reson Med. 1997;179-182.

    Not in our library10.1002/mrm.1910380203

  70. 70.

    Marro KI, Lee D, Shankland EG, et al. Synthetic signal injection using inductive coupling. J Magn Reson. 2008;194:67-75.

    Not in our library10.1016/j.jmr.2008.05.022

  71. 71.

    El-Sharkawy AM, Gabr RE, Schar M, Weiss RG, Bottomley PA. Quantification of human high-energy phosphate metabolite concentrations at 3 T with partial volume and sensitivity corrections. NMR Biomed. 2013;26(11):1363-1371.

    Not in our library10.1002/nbm.2961

  72. 72.

    Harris R, Edwards R, Hultman E, Nordesjö L, Nylind B, Sahlin K. The time course of phosphorylcreatine resynthesis during recovery of the quadriceps muscle in man. Pflugers Arch. 1976;367(2):137-142.

    Not in our library10.1007/bf00585149

  73. 73.

    Arsac LM, Thiaudiere E, Diolez P, Gerville-Réache L. Parameter estimation in modeling phosphocreatine recovery in human skeletal muscle. Eur J Appl Physiol. 2004;91(4):419-424.

    Not in our library10.1007/s00421-003-1001-5

  74. 74.

    Forbes SC, Slade JM, Francis RM, Meyer RA. Comparison of oxidative capacity among leg muscles in humans using gated 31P 2-D chemical shift imaging. NMR Biomed. 2009;22:1063-1071.

    Not in our library10.1002/nbm.1413

  75. 75.

    Ferrari M, Muthalib M, Quaresima V. The use of near-infrared spectroscopy in understanding skeletal muscle physiology: recent developments. Philos Transact A Math Phys Eng Sci. 2011;369:1-14.

    Not in our library10.1098/rsta.2011.0230

  76. 76.

    Bendahan D, Chatel B, Jue T. Comparative NMR and NIRS analysis of oxygen-dependent metabolism in exercising finger flexor muscles. Am J Physiol Regul Integr Comp Physiol. 2017;313(6):R740-R753.

    Not in our library10.1152/ajpregu.00203.2017

  77. 77.

    Tran TK, Sailasuta N, Kreutzer U, et al. Comparative analysis of NMR and NIRS measurements of intracellular PO2 in human skeletal muscle. Am J Physiol. 1999;276:R1682-R1690.

    Not in our library10.1152/ajpregu.1999.276.6.r1682

  78. 78.

    Davis ML, Barstow TJ. Estimated contribution of hemoglobin and myoglobin to near infrared spectroscopy. Respir Physiol Neurobiol. 2013;186(2):180-187.

    Not in our library10.1016/j.resp.2013.01.012

  79. 79.

    Forbes SC, Kowalchuk JM, Thompson RT, Marsh GD. Effects of hyperventilation on phosphocreatine kinetics and muscle deoxygenation during moderate-intensity plantar flexion exercise. J Appl Physiol. 2007;102:1565-1573.

    Not in our library10.1152/japplphysiol.00895.2006

  80. 80.

    Kent-Braun JA, Sharma KR, Weiner MW, Massie B, Miller RG. Central basis of muscle fatigue in chronic fatigue syndrome. Neurology. 1993;43:125-131.

    Not in our library10.1212/wnl.43.1_part_1.125

  81. 81.

    Frank LR, Wong EC, Haseler LJ, Buxton RB. Dynamic imaging of perfusion in human skeletal muscle during exercise with arterial spin labelling. Magn Reson Med. 1999;42:258-267.

    Not in our library10.1002/(sici)1522-2594(199908)42:2<258::aid-mrm7>3.0.co;2-e

  82. 82.

    Lebon V, Brillault-Salvat C, Bloch G, Leroy-Willig A, Carlier PG. Evidence of muscle BOLD effect revealed by simultaneous interleaved gradient-echo NMRI and myoglobin NMRS during leg ischemia. Magn Reson Med. 1998;40:551-558.

    Not in our library10.1002/mrm.1910400408

  83. 83.

    Carlier PG, Bertoldi D, Baligand C, Wary C, Fromes Y. Muscle blood flow and oxygenation measured by NMR. NMR Biomed. 2006;954-967.

    Not in our library10.1002/nbm.1081

  84. 84.

    Schmid AI, Schewzow K, Fiedler GB, et al. Exercising calf muscle T 2 * changes correlate with pH, PCr recovery and maximum oxidative phosphorylation. NMR Biomed. 2014;27:553-560.

    Not in our library10.1002/nbm.3092

  85. 85.

    Towse TF, Slade JM, Ambrose JA, DeLano MC, Meyer RA. Quantitative analysis of the postcontractile blood-oxygenation-level-dependent (BOLD) effect in skeletal muscle. J Appl Physiol. 2011;111:27-39.

    Not in our library10.1152/japplphysiol.01054.2009

  86. 86.

    Bakermans AJ, Wessel CH, Zheng KH, Groot PFC, Stroes ESG, Nederveen AJ. Dynamic magnetic resonance measurements of calf muscle oxygenation and energy metabolism in peripheral artery disease. J Magn Reson Imaging. 2019;1-10.

    Not in our library10.1002/jmri.26841

  87. 87.

    Brillault-Salvat C, Giacomini E, Wary C, et al. An interleaved heteronuclear NMRI-NMRS approach to non-invasive investigation of exercising human skeletal muscle. Cell Mol Biol (Noisy-le-Grand). 1997;43:751-762.

    Not in our library

  88. 88.

    Wray DW, Nishiyama SK, Monnet A, et al. Multiparametric NMR-based assessment of skeletal muscle perfusion and metabolism during exercise in elderly persons: preliminary findings. J Gerontol A Biol Sci Med Sci. 2009;64:968-974.

    Not in our library10.1093/gerona/glp044

  89. 89.

    Niess F, Schmid AI, Bogner W, et al. Interleaved 31P MRS/1H ASL for analysis of metabolic and functional heterogeneity along human lower leg muscles at 7T. Magn Reson Med. 2019.

    Not in our library10.1002/mrm.28088

  90. 90.

    Duteil S, Bourrilhon C, Raynaud JS, et al. Metabolic and vascular support for the role of myoglobin in humans: a multiparametric NMR study. Am J Physiol Regul Integr Comp Physiol. 2004;287:R1441-R1449.

    Not in our library10.1152/ajpregu.00242.2004

  91. 91.

    Meyerspeer M, Kemp GJ, Mlynárik V, et al. Direct noninvasive quantification of lactate and high energy phosphates simultaneously in exercising human skeletal muscle by localized magnetic resonance spectroscopy. Magn Reson Med. 2007;57:654-660.

    Not in our library10.1002/mrm.21188

  92. 92.

    Lopez Kolkovsky AL, Reyngoudt H, Giacomini E, Niess F, Meyerspeer M, Carlier PG. pH evaluation in the exercising muscle by interleaved localized NMR spectroscopy of carnosine and inorganic phosphate. 2017.

    Not in our library

  93. 93.

    Meyerspeer M, Magill AW, Kuehne A, Gruetter R, Moser E, Schmid AI. Simultaneous and interleaved acquisition of NMR signals from different nuclei with a clinical MRI scanner. Magn Reson Med. 2016;76:1636-1641.

    Not in our library10.1002/mrm.26056

  94. 94.

    Parasoglou P, Xia D, Chang G, Regatte RR. Dynamic three-dimensional imaging of phosphocreatine recovery kinetics in the human lower leg muscles at 3T and 7T: a preliminary study. NMR Biomed. 2013;26(3):348-356.

    Not in our library10.1002/nbm.2866

  95. 95.

    Šedivý P, Kipfelsberger MC, Dezortová M, et al. Dynamic 31P MR spectroscopy of plantar flexion: influence of ergometer design, magnetic field strength (3 and 7 T), and RF-coil design. Med Phys. 2015;42:1678-1689.

    Not in our library10.1118/1.4914448

  96. 96.

    Šedivý P, Dezortová M, Rydlo J, et al. MR compatible ergometers for dynamic 31P MRS. J Appl Biomed. 2019;17:91-98.

    Not in our library10.32725/jab.2019.006

  97. 97.

    Jeneson JAL, Bruggeman FJ. Robust homeostatic control of quadriceps pH during natural locomotor activity in man. FASEB J. 2004;18:1010-1012.

    Not in our library10.1096/fj.03-0762fje

  98. 98.

    Hoppeler H, Herzog W. Eccentric exercise: many questions unanswered. J Appl Physiol. 2014;116:1405-1406.

    Not in our library10.1152/japplphysiol.00239.2014

  99. 99.

    Ryschon TW, Fowler MD, Wysong RE, Anthony A, Balaban RS. Efficiency of human skeletal muscle in vivo: comparison of isometric, concentric, and eccentric muscle action. J Appl Physiol. 1997;83:867-874.

    Not in our library10.1152/jappl.1997.83.3.867

  100. 100.

    Marsh GD, Paterson DH, Thompson RT, Driedger AA. Coincident thresholds in intracellular phosphorylation potential and pH during progressive exercise. J Appl Physiol. 1991;71(3):1076-1081.

    Not in our library10.1152/jappl.1991.71.3.1076

  101. 101.

    Larsen RG, Callahan DM, Foulis SA, Kent-Braun JA. Age-related changes in oxidative capacity differ between locomotory muscles and are associated with physical activity behavior. Appl Physiol Nutr Metab. 2012;37:88-99.

    Not in our library10.1139/h11-135

  102. 102.

    Walter G, Vandenborne K, McCully KK, Leigh JS. Noninvasive measurement of phosphocreatine recovery kinetics in single human muscles. Am J Physiol. 1997;272(2 Pt 1):C525-C534.

    Not in our library10.1152/ajpcell.1997.272.2.c525

  103. 103.

    Quistorff B, Johansen L, Sahlin K. Absence of phosphocreatine resynthesis in human calf muscle during ischaemic recovery. Biochem J. 1993;291:681-686.

    Not in our library10.1042/bj2910681

  104. 104.

    Layec G, Bringard A, Le Fur Y, et al. Reproducibility assessment of metabolic variables characterizing muscle energetics in vivo: a 31P-MRS study. Magn Reson Med. 2009;62(4):840-854.

    Not in our library10.1002/mrm.22085

  105. 105.

    Crow MT, Kushmerick MJ. Chemical energetics of slow- and fast-twitch muscles of the mouse. J Gen Physiol. 1982;79:147-166.

    Not in our library10.1085/jgp.79.1.147

  106. 106.

    Kemp GJ. eMagRes. 2015;4:525-534.

    Not in our library

  107. 107.

    Kushmerick MJ, Moerland TS, Wiseman RW. Mammalian skeletal muscle fibers distinguished by contents of phosphocreatine, ATP, and Pi. Proc Natl Acad Sci U S A. 1992;89(16):7521-7525.

    Not in our library10.1073/pnas.89.16.7521

  108. 108.

    Takahashi H, Kuno SY, Katsuta S, et al. Relationships between fiber composition and NMR measurements in human skeletal muscle. NMR Biomed. 1996;9(1):8-12.

    Not in our library10.1002/(sici)1099-1492(199602)9:1<8::aid-nbm387>3.0.co;2-f

  109. 109.

    Taylor DJ, Kemp GJ, Radda GK. Bioenergetics of skeletal muscle in mitochondrial myopathy. J Neurol Sci. 1994;127(2):198-206.

    Not in our library10.1016/0022-510x(94)90073-6

  110. 110.

    Heerschap A, den Hollander JA, Reynen H, Goris RJ. Metabolic changes in reflex sympathetic dystrophy: a 31P NMR spectroscopy study. Muscle Nerve. 1993;16(4):367-373.

    Not in our library10.1002/mus.880160405

  111. 111.

    Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J Neurol Sci. 1993;116(2):201-206.

    Not in our library10.1016/0022-510x(93)90326-t

  112. 112.

    Jubrias SA, Bennett RM, Klug GA. Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients. Arthritis Rheum. 1994;37(6):801-807.

    Not in our library10.1002/art.1780370604

  113. 113.

    Sastrustegui J, Berkowitz H, Boden B, et al. An in vivo phosphorus nuclear magnetic resonance study of the variations with age in the phosphodiester content of human muscle. Mech Ageing Dev. 1988;42:105-114.

    Not in our library10.1016/0047-6374(88)90066-8

  114. 114.

    Argov Z, Lofberg M, Arnold DL. Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle Nerve. 2000;23(9):1316-1334.

    Not in our library10.1002/1097-4598(200009)23:9<1316::aid-mus2>3.0.co;2-i

  115. 115.

    Paganini AT, Foley JM, Meyer RA. Linear dependence of muscle phosphocreatine kinetics on oxidative capacity. Am J Physiol. 1997;272(2 Pt 1):C501-C510.

    Not in our library10.1152/ajpcell.1997.272.2.c501

  116. 116.

    Larson-Meyer DE, Newcomer BR, Hunter GR, Hetherington HP, Weinsier RL. 31P MRS measurement of mitochondrial function in skeletal muscle: reliability, force-level sensitivity and relation to whole body maximal oxygen uptake. NMR Biomed. 2000;13(1):14-27.

    Not in our library10.1002/(sici)1099-1492(200002)13:1<14::aid-nbm605>3.0.co;2-0

  117. 117.

    McCully KK, Fielding RA, Evans WJ, Leigh JS, Posner JD. Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles. J Appl Physiol. 1993;75(2):813-819.

    Not in our library10.1152/jappl.1993.75.2.813

  118. 118.

    Jubrias SA, Crowther GJ, Shankland EG, Gronka RK, Conley KE. Acidosis inhibits oxidative phosphorylation in contracting human skeletal muscle in vivo. J Physiol. 2003;553(Pt 2):589-599.

    Not in our library10.1113/jphysiol.2003.045872

  119. 119.

    Layec G, Malucelli E, Le Fur Y, et al. Effects of exercise-induced intracellular acidosis on the phosphocreatine recovery kinetics: a 31P MRS study in three muscle groups in humans. NMR Biomed. 2013;26(11):1403-1411.

    Not in our library10.1002/nbm.2966

  120. 120.

    van den Broek NM, De Feyter HM, de Graaf L, Nicolay K, Prompers JJ. Intersubject differences in the effect of acidosis on phosphocreatine recovery kinetics in muscle after exercise are due to differences in proton efflux rates. Am J Physiol Cell Physiol. 2007;293(1):C228-C237.

    Not in our library10.1152/ajpcell.00023.2007

  121. 121.

    Kent JA, Fitzgerald LF. In vivo mitochondrial function in aging skeletal muscle: capacity, flux, and patterns of use. J Appl Physiol. 2016;121:996-1003.

    Not in our library10.1152/japplphysiol.00583.2016

  122. 122.

    Kemp GJ. Mitochondrial dysfunction in chronic ischemia and peripheral vascular disease. Mitochondrion. 2004;4(5–6):629-640.

    Not in our library10.1016/j.mito.2004.07.017

  123. 123.

    Layec G, Haseler LJ, Trinity JD, et al. Mitochondrial function and increased convective O2 transport: implications for the assessment of mitochondrial respiration in vivo. J Appl Physiol (1985). 2013;115(6):803-811.

    Not in our library10.1152/japplphysiol.00257.2013

  124. 124.

    Haseler LJ, Lin A, Hoff J, Richardson RS. Oxygen availability and PCr recovery rate in untrained human calf muscle: evidence of metabolic limitation in normoxia. Am J Physiol Regul Integr Comp Physiol. 2007;293(5):R2046-R2051.

    Not in our library10.1152/ajpregu.00039.2007

  125. 125.

    Payen JF, Wuyam B, Levy P, et al. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis. 1993;147(3):592-598.

    Not in our library10.1164/ajrccm/147.3.592

  126. 126.

    Kemp GJ, Tonon C, Malucelli E, et al. Cytosolic pH buffering during exercise and recovery in skeletal muscle of patients with McArdle's disease. Eur J Appl Physiol. 2009;105(5):687-694.

    Not in our library10.1007/s00421-008-0950-0

  127. 127.

    Park JH, Brown RL, Park CR, et al. Functional pools of oxidative and glycolytic fibers in human muscle observed by 31P magnetic resonance spectroscopy during exercise. Proc Natl Acad Sci U S A. 1987;84(24):8976-8980.

    Not in our library10.1073/pnas.84.24.8976

  128. 128.

    Vandenborne K, McCully K, Kakihira H, et al. Metabolic heterogeneity in human calf muscle during maximal exercise. Proc Natl Acad Sci U S A. 1991;88(13):5714-5718.

    Not in our library10.1073/pnas.88.13.5714

  129. 129.

    Houtman CJ, Heerschap A, Zwarts MJ, Stegeman DF. pH heterogeneity in tibial anterior muscle during isometric activity studied by 31P-NMR spectroscopy. J Appl Physiol. 2017;91:191-200.

    Not in our library10.1152/jappl.2001.91.1.191

  130. 130.

    Befroy DE, Falk Petersen K, Rothman DL, Shulman GI. Assessment of in vivo mitochondrial metabolism by magnetic resonance spectroscopy. Methods Enzymol. 2009;457:373-393.

    Not in our library10.1016/s0076-6879(09)05021-6

  131. 131.

    Schmid AI, Schrauwen-Hinderling VB, Andreas M, Wolzt M, Moser E, Roden M. Comparison of measuring energy metabolism by different 31P- magnetic resonance spectroscopy techniques in resting, ischemic, and exercising muscle. Magn Reson Med. 2012;67:898-905.

    Not in our library10.1002/mrm.23095

  132. 132.

    Wary C, Naulet T, Thibaud JL, Monnet A, Blot S, Carlier PG. Splitting of Pi and other 31P NMR anomalies of skeletal muscle metabolites in canine muscular dystrophy. NMR Biomed. 2012;25:1160-1169.

    Not in our library10.1002/nbm.2785

  133. 133.

    Conley KE, Ali AS, Flores B, Jubrias SA, Shankland EG. Mitochondrial NAD(P)H in vivo: identifying natural indicators of oxidative phosphorylation in the 31P magnetic resonance spectrum. Front Physiol. 2016;7:45.

    Not in our library10.3389/fphys.2016.00045

  134. 134.

    Moon RB, Richards JH. Determination of intracellular pH by 31P magnetic resonance. J Biol Chem. 1973;248(20):7276-7278.

    Not in our library

  135. 135.

    Lüthi D, Günzel D, McGuigan JAS. Mg-ATP binding: its modification by spermine, the relevance to cytosolic Mg2+ buffering, changes in the intracellular ionized Mg2+ concentration and the estimation of Mg2+ by 31P-NMR. Exp Physiol. 1999.

    Not in our library

  136. 136.

    Halvorson HR, Vande Linde AMQ, Helpern JA, Welch KMA. Assessment of magnesium concentrations by 31P NMR in vivo. NMR Biomed. 1992;5:53-58.

    Not in our library10.1002/nbm.1940050202

  137. 137.

    Rodgers CT, Clarke WT, Snyder C, Vaughan JT, Neubauer S, Robson MD. Human cardiac 31P magnetic resonance spectroscopy at 7 tesla. Magn Reson Med. 2014;72:304-315.

    Not in our library10.1002/mrm.24922

  138. 138.

    Wiseman RW, Kushmerick MJ. Creatine kinase equilibration follows solution thermodynamics in skeletal muscle. 31P NMR studies using creatine analogs. J Biol Chem. 1996;270:12428-12438.

    Not in our library10.1074/jbc.270.21.12428

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.